Matthew J. Hoffman

Matthew J. Hoffman

Auto-generated profile, based on publicly available information

Matthew J. Hoffman

Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2019
Verified
Book Chapter
Closed access
PDF file
SLStanley J. F. Laulederkind
Stanley J. F. Laulederkind
GHG. T. Hayman
G. T. Hayman
SWShur-Jen Wang
Shur-Jen Wang
MHMatthew J. Hoffman
Matthew J. Hoffman
JSJennifer R. Smith
Jennifer R. Smith
MSMary Shimoyama
Mary Shimoyama

3 May 2022 in Physiological Genomics
Verified
Journal Article
Closed access
PDF file
MHMatthew J. Hoffman
Matthew J. Hoffman
ATAkiko Takizawa
Akiko Takizawa
EJEric S. Jensen
Eric S. Jensen
RSRebecca Schilling
Rebecca Schilling
MGMichael Grzybowski
Michael Grzybowski
MDMelinda R. Dwinell
Melinda R. Dwinell
Hypertension (HTN) is a complex disease influenced by heritable genetic elements and environmental interactions. Dietary salt is among the most influential modifiable factors contributing to increased blood pressure (BP). It is well established that men and women develop BP impairment in different patterns and a recent emphasis has been placed on identifying mechanisms leading to the differences observed between the sexes in HTN development. The current work reported here builds on an extensive genetic mapping experiment that sought to identify genetic determinants of salt-sensitive (SS) HTN using the Dahl SS rat. BTG antiproliferation factor 2 (Btg2) was previously identified by our group as a candidate gene contributing to SS HTN in female rats. In the current study, Btg2 was mutated using transcription activator-like effector nuclease (TALEN)-targeted gene disruption on the SSBN congenic rat background. The Btg2 mutated rats exhibited impaired BP and proteinuria responses to a high-salt diet compared with wild-type rats. Differences in body weight, mutant pup viability, skeletal morphology, and adult nephron density suggest a potential role for Btg2 in developmental signaling pathways. Subsequent cell cycle gene expression assessment provides several additional signaling pathways that Btg2 may function through during salt handling in the kidney. The expression analysis also identified several potential upstream targets that can be explored to further isolate therapeutic approaches for SS HTN.